Yes, PCOS is associated with higher white blood cell counts. Studies consistently show that women with PCOS have significantly elevated white blood cell levels compared to healthy women of the same age. In one well-known study, women with PCOS averaged 7,260 white blood cells per cubic millimeter, compared to 5,220 in healthy controls. Another found counts roughly 30% higher in the PCOS group. These elevations typically fall within or just above the normal laboratory range, so they don’t signal an acute infection. Instead, they reflect something called chronic low-grade inflammation, a persistent, simmering immune response that’s now considered a core feature of the condition.
Why PCOS Raises White Blood Cell Counts
PCOS creates a metabolic environment that keeps the immune system on a low simmer. Fat tissue, insulin resistance, hormone imbalances, and shifts in gut bacteria all contribute to a state where the body produces more pro-inflammatory signaling molecules (particularly IL-6 and TNF-alpha). These signals tell the bone marrow to release more white blood cells, especially neutrophils, into the bloodstream. Researchers have also found higher-than-normal infiltration of immune cells like macrophages and lymphocytes in multiple organ systems of women with PCOS, not just the ovaries but also the liver, intestines, thyroid, and cardiovascular tissue.
This isn’t the kind of inflammation you can feel, like a swollen ankle or sore throat. It’s a subtle, body-wide process that often shows up only on blood work. But over time, the chronic activation of the immune system feeds back into the metabolic problems that drive PCOS, creating a cycle: inflammation worsens insulin resistance, which worsens inflammation.
Obesity and Insulin Resistance Are the Biggest Drivers
Not all factors contribute equally. Research involving 203 women with PCOS and 76 controls found that body weight and insulin resistance are the two leading forces behind elevated white blood cell counts, and they stack on top of each other. The strongest correlation was with BMI. Insulin levels and a measure of insulin resistance called the HOMA score also tracked closely with white blood cell counts. Interestingly, high androgen levels (the excess testosterone often seen in PCOS) did not independently affect white blood cell counts once weight and insulin resistance were accounted for.
Among women with PCOS who were overweight, those with insulin resistance had significantly higher white blood cell counts than those without it. This means two women with PCOS and the same body weight can have different levels of inflammation depending on how their bodies handle insulin.
Lean Women With PCOS Are Affected Too
A common assumption is that excess weight explains the inflammation seen in PCOS. It doesn’t tell the whole story. A BMI-matched case-control study compared lean PCOS patients to lean controls and obese PCOS patients to obese controls. In both comparisons, the women with PCOS had higher leukocyte counts, higher neutrophil counts, and higher inflammatory markers than their weight-matched peers. Lean PCOS patients averaged a white blood cell count of 7,200 compared to 5,600 in lean controls. This suggests the inflammatory process is partly intrinsic to the syndrome itself, not just a byproduct of carrying extra weight.
Which White Blood Cells Are Most Affected
The elevation isn’t uniform across all types of white blood cells. Neutrophils, the most abundant type and the body’s first responders to inflammation, account for much of the increase. Researchers use a ratio of neutrophils to lymphocytes (another type of white blood cell) as a quick marker of systemic inflammation. Women with PCOS consistently show a higher neutrophil-to-lymphocyte ratio than controls, and the ratio is even more pronounced in those who are obese. This ratio correlates with insulin resistance and with C-reactive protein, another well-established inflammation marker that’s also elevated in PCOS.
What This Means for Long-Term Health
White blood cell count is an independent risk factor for cardiovascular disease in women. The persistent, low-grade immune activation seen in PCOS is one reason the condition is linked to a higher risk of atherosclerosis, heart disease, and type 2 diabetes over time. One study found a near-linear relationship between white blood cell count and insulin resistance in women with PCOS, with a correlation coefficient of 0.94, an unusually tight link. C-reactive protein levels were also nearly three times higher in the PCOS group (2.0 mg/L vs. 0.7 mg/L). Together, these markers paint a picture of cardiovascular risk that begins well before any symptoms of heart disease appear.
This doesn’t mean every woman with PCOS will develop heart disease. It does mean that chronic inflammation is a meaningful piece of the metabolic puzzle, and addressing it can improve the overall trajectory.
Exercise and Medication Can Lower the Count
The encouraging news is that white blood cell counts in PCOS respond to treatment. In a six-month prospective study, women with PCOS who took metformin (a common medication for insulin resistance) saw their average white blood cell count drop from 7,050 to 6,080 cells per cubic millimeter. C-reactive protein levels fell in parallel. These were normal-weight women with no additional metabolic diseases, so the improvement wasn’t simply a side effect of weight loss.
Exercise produces similar results. A 16-week aerobic exercise program reduced white blood cell counts significantly in women with PCOS, and the drop correlated directly with improvements in insulin sensitivity. Women whose bodies became better at processing glucose saw the largest reductions in circulating neutrophils and total white blood cells. The relationship was strong: the correlation between improved glucose disposal and reduced neutrophil counts reached -0.82, meaning the two moved almost in lockstep.
These findings reinforce that chronic inflammation in PCOS isn’t fixed. It’s a metabolic consequence that responds when the underlying drivers, particularly insulin resistance, are addressed through lifestyle changes, medication, or both.